Slingshot members are tracking this event:

Portola (PTLA) Expects Committee for Medicinal Products for Human Use (CHMP) Opinion in Q4 for Betrixaban in Prevention of VTE in Acute Medically Ill Patients

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 23, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Chmp, Opinion, Betrixaban, Prevention Of Vte, Acute Medically Ill Patients